Michelle Bent-Morgan Marcrese McDaniel Vitalii Stadnyk, PhD.

Slides:



Advertisements
Similar presentations
HPV Testing and Genotyping
Advertisements

Clinical Use of HPV DNA Testing Thomas C. Wright, Jr. College of Physicians and Surgeons of Columbia University.
SIS – NBS Online Specimen Tracking System Training
MANAGEMENT OF THE ABNORMAL PAP SMEAR
M. Munjoma. Outline Burden of HPV Disease HPV in Zimbabwe HPV Lab Development HPV Protocols.
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Clinical Uses of HPV DNA Testing
20 February Set Up Access Groups. 20 February Access Group Definition Combines time zones and doors into groups of where and when access can.
Radius Search.  Radius searches allow you to retrieve properties that fall within a selected radius around a subject property. Furthermore, you can select.
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
Cervical Cancer Screening Recommendations 2012, FDA Panel 2014.
Nextgen GL ACCOUNT CREATE, EDIT,& SEARCH. GL Account Creation Adding the account to the COA Creating & adding the account to the GL Nextgen.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
David Y. Zhang MD, PhD, MPH Professor Director, Molecular Pathology Departments of Pathology Icahn School of Medicine at Mount Sinai, New York Molecular.
1 Cervical Screening Programme, England, : Graphs.
Cervical Intraepithelial Neoplasm
Nextgen Transactions Presented by Bridget Clayton Local Government Corporation Resource 2015.
Nextgen Transactions Presented by Bridget Clayton Local Government Corporation Resource 2014.
NextGen Financial Management Transactions & Account Inquiry Presented by Local Government Corporation Resource 2016 Presented by Local Government Corporation.
New Technologies in cervical cancer screening Cosette Wheeler, University of New Mexico Albuquerque, New Mexico.
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
4.0.7 New Features Presented by Nicholas Felts. What version are you on? A or lower B C D.Live on E.Going to
SoftTotalQC® : Sporting New Features and Taking the Gold with Stronger Standards and Higher Performance! Presented by: Isis Smith, MLS(ASCP) SCC SoftTotalQC.
Contact: PRELIMINARY RESULTS OF FIRST HPV PRIMARY SCREENING PRIVATE SECTOR IN BUENOS AIRES FEMALE POPULATION R. Jiménez del Toro,
Discussion & Conclusion
Public Health England leads the NHS Screening Programmes
Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,
Cost-effectiveness Analysis for Cervical Cancer Screening Using HPV DNA Tests in Chile Franco Figueira S, BPharm student1; Cachoeira CV, MD, MBA1; Silva.
Prevalence of oncogenic Human Papillomavirus genotypes in women with vulvar and cervical squamous cell carcinoma in Botswana Patricia Rantshabeng1,2 ,
HCV by PCR Neelam Gajjar 7/26/2009.
SoftLab 4.5 Overview Archie Dennis.
Receiving New Lending requests
From: Inefficiencies and High-Value Improvements in U. S
Copyright © 2015 by the American Osteopathic Association.
NHS Cervical Screening Programme, England, : Graphs
RevConnect Ineligible Patient Custom Reports
Retest in 12mo with HPV testing
Mission SoftTotalQC: Navigating Your Quality Control Concerns
This presentation document has been prepared by Vault Intelligence Limited (“Vault") and is intended for off line demonstration, presentation and educational.
QUIZ QUESTIONS 1) WHAT ARE THE TWO TYPES OF CERVICAL CANCER?
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia  A. Gradíssimo Oliveira, C. Delgado,
The Future of SoftBank Presented by:
NextGen Trustee General Ledger Accounting
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia  A. Gradíssimo Oliveira, C. Delgado,
BB instrument interfaces - setup - workflow - troubleshooting
Lesson Nine: Epic Appointment Scheduling Referrals Reports
This presentation has been prepared by Vault Intelligence Limited (“Vault") and is intended for off line demonstration, presentation and educational purposes.
Upgrading from SoftPath to SoftPathDx “Passing of the Torch” Presented by: Christine Comella SoftPathDx Implementation Specialist.
Web site: BioSciCon, Inc. Business Opportunity 2006 Web site: January 15, 2019.
Integrated Epidemiology Reports
Public Health England leads the NHS Screening Programmes
Neonate Handling in SoftBank
Lesson Nine: Epic Appointment Scheduling Referrals Reports
Lesson Nine: Epic Appointment Scheduling Referrals Reports
Cervical Screening for Dysplasia and Cancer in Patients with HIV
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis  Chunqing Lin,
COURSE OBJECTIVES Review Case Comparison
The National Cervical Screening Programme
Modern cervical cancer screening
Horizon 2020 EarLy dEtection of cerVical cAncer in hard-to-reach populations: development and implementation of a new HPV test combining self-sampling.
Real-Time Acquisition (RTA) integration with OASIS platform
Fig. 3. The examinations consumed by the three cervical screening strategies to detect CIN2+/CIN3+. (A) The cases of CIN2+ detected by three current cervical.
Fig. 2. Three cervical screening strategies to detect CIN2+/CIN3+
Fig. 1. Flowchart of inclusion and exclusion criteria of the study population.ASC-US, atypical squamous cells of undetermined significance; CIN, cervical.
American Society of Cytopathology’s CELL Talks
New Features in Security Management
Presentation transcript:

Michelle Bent-Morgan Marcrese McDaniel Vitalii Stadnyk, PhD. HPV in SoftMolecular Michelle Bent-Morgan Marcrese McDaniel Vitalii Stadnyk, PhD.

Outline What is HPV? Importance of testing FDA approved platforms Configuration in SoftMolecular Process and Reporting in SoftMolecular

What is HPV? HPV is a small, nonenveloped, double-stranded DNA virus genome Size of approximately 8,000 nucleotides. more than 118 different types of HPV approximately 40 different HPVs that can infect the human anogenital mucosa

data suggests that 14 of these types are most clinically significant Types of HPV: data suggests that 14 of these types are most clinically significant

Clinical significance and importance of HPV testing yearly, over 27,000 women and men are affected by a cancer caused by HPV

Clinical significance and importance of HPV testing According to CDC data, Persistent HPV infection can cause cervical and other cancers *Note: Many of these cancers may be related to tobacco and alcohol use

FDA Approved (IVD) platforms used for HPV testing

Cobas 4800 HPV test is a high-risk–HPV DNA-based PCR screening assay with capability for concurrent genotyping for HPV 16 and HPV 18 by real-time PCR.

Nucleic acid (DNA) testing by PCR has become a standard, noninvasive method for determining the presence of a cervical HPV infection. Proper implementation of nucleic acid testing for HPV may 1) increase the sensitivity of cervical cancer screening programs by detecting high-risk lesions earlier in women 30 years and older with normal cytology and 2) reduce the need for unnecessary colposcopy and treatment in patients 21 and older with cytology results showing atypical squamous cells of undetermined significance (ASC-US).

Nucleic acid (DNA) testing by PCR has become a standard, noninvasive method for determining the presence of a cervical HPV infection. Proper implementation of nucleic acid testing for HPV may increase the sensitivity of cervical cancer screening programs by detecting high-risk lesions earlier in women 30 years and older with normal cytology and reduce the need for unnecessary colposcopy and treatment in patients 21 and older with cytology results showing atypical squamous cells of undetermined significance (ASC-US).

Setting up HPV in SoftMolecular 1. Need action to create protocol 2 Setting up HPV in SoftMolecular 1. Need action to create protocol 2. Create protocol 3. Create report template 4. Create test 5. Create tasklist

We need an Aliquot action in our protocol

Creation of Specimen Protocol

Create report template Create test.

Test Specific Report Template

An integrated report Template

Test Definition

Actions to perform on test

List of acceptable specimens

Creation of Result fields

Performing department and workstation need for DMI and SoftTQC

Result QC to show abnormal flagging of result on tasklist

Test Run Rules need for DMI configuration to send results back to Softmolecular

Test Reporting Rules for defaulting Interpretation on tasklist

Creation of Tasklist template

Test Setup showing Tasklist linkage for Automatic DMI tasklist build

Where do we get our samples From Softlab, Directly entered into SoftMolecular or PathDXP as a reflex test. Samples can come thru Specimen receiving worklist, Dept Received or directly in Specimen Prep based on setup and integration

Reflex from SoftPathDX

Specimen Processing in Softmolecular In toolbar, click Processing then Specimen Preparation

Search by Test name for list of all orders pending for that test Or search by Order # if its one order only or Protocols

Processing in Cobas interface with DMI and SoftMolecular. Load the Cobas by scanning the Specimen bar code Once the Cobas instrument completes running the test After the instrument finishes running click send results to LIS in the instrument

Open SoftMolecular main screen In toolbar, click Result then Tasklist

Search by Built Tasklist search and use the Date range as search criteria (RUN DATE)

Select Tasklist# and External Batch # that matches your run

Results Downloaded by DMI to SoftMolecular

Results from Instrument are downloaded and base on RBS setup, rules are set to run to default interpretation

Once the tasklist open, Review imported results (Data received symbol) Review QC Results Check the completed box to complete Test Manual Review Action and Click Save Click Edit, Detected Results will be highlighted in Red.

Control Results Downloaded by DMI to SoftTQC

Test Specific Report

An Integrated Report Showing Molecular and Cytology Results

Reference Human Papillomavirus (HPV) and Cancer. (2016). Retrieved April 01, 2016, from http://www.cdc.gov/cancer/hpv/index.htm MLO Staff. (n.d.). Retrieved April 01, 2016, from http://www.mlo-online.com/the-five-fda-approved-hpv-assays.php  cobas® 4800 System . (n.d.). Retrieved March 18, 2016, from http://molecular.roche.com/instruments/Pages/cobas4800System.aspx